Oxygen for relief of dyspnoea in people with chronic obstructive pulmonary disease who would not qualify for home oxygen: a systematic review and meta-analysis

Hope Uronis; Magnus Ekstrom; David Currow; D McCrory; G Samsa; Amy Abernethy

doi:10.1136/thoraxjnl-2014-205720

Oxygen for relief of dyspnoea in people with chronic obstructive pulmonary disease who would not qualify for home oxygen: a systematic review and meta-analysis

Hope Uronis, Magnus Ekstrom, David Currow, D McCrory, G Samsa, Amy Abernethy

Research output: Contribution to journal › Review article › peer-review

35 Citations (Scopus)

Abstract

We searched MEDLINE, EMBASE and the Cochrane Controlled Trials Register to determine whether oxygen relieves dyspnoea in mildly or non-hypoxemic COPD and included 18 randomised controlled trials (431 participants) in the meta-analysis using Cochrane methodology. Oxygen therapy reduced dyspnoea when compared with medical air; standardised mean difference -0.37 (95% CI -0.50 to -0.24; I²=14%). In a priori subgroup and sensitivity analyses, dyspnoea was reduced by continuous oxygen during exertion but not short-burst oxygen therapy. Continuous exertional oxygen can relieve dyspnoea in mildly or non-hypoxemic COPD, but evidence from larger clinical trials is needed.

Original language	English
Pages (from-to)	492-494
Number of pages	3
Journal	Thorax
Volume	70
Issue number	5
DOIs	https://doi.org/10.1136/thoraxjnl-2014-205720
Publication status	E-pub ahead of print - 2014

Access to Document

10.1136/thoraxjnl-2014-205720

Fingerprint Dive into the research topics of 'Oxygen for relief of dyspnoea in people with chronic obstructive pulmonary disease who would not qualify for home oxygen: a systematic review and meta-analysis'. Together they form a unique fingerprint.

Cite this

@article{a4352b5ceb3e4a5ab2c90b67d2da6cd9,

title = "Oxygen for relief of dyspnoea in people with chronic obstructive pulmonary disease who would not qualify for home oxygen: a systematic review and meta-analysis",

abstract = "We searched MEDLINE, EMBASE and the Cochrane Controlled Trials Register to determine whether oxygen relieves dyspnoea in mildly or non-hypoxemic COPD and included 18 randomised controlled trials (431 participants) in the meta-analysis using Cochrane methodology. Oxygen therapy reduced dyspnoea when compared with medical air; standardised mean difference -0.37 (95% CI -0.50 to -0.24; I2=14%). In a priori subgroup and sensitivity analyses, dyspnoea was reduced by continuous oxygen during exertion but not short-burst oxygen therapy. Continuous exertional oxygen can relieve dyspnoea in mildly or non-hypoxemic COPD, but evidence from larger clinical trials is needed.",

author = "Hope Uronis and Magnus Ekstrom and David Currow and D McCrory and G Samsa and Amy Abernethy",

year = "2014",

doi = "10.1136/thoraxjnl-2014-205720",

language = "English",

volume = "70",

pages = "492--494",

journal = "Thorax",

issn = "0040-6376",

publisher = "British Medical Journal Publishing Group",

number = "5",

}

TY - JOUR

T1 - Oxygen for relief of dyspnoea in people with chronic obstructive pulmonary disease who would not qualify for home oxygen: a systematic review and meta-analysis

AU - Uronis, Hope

AU - Ekstrom, Magnus

AU - Currow, David

AU - McCrory, D

AU - Samsa, G

AU - Abernethy, Amy

PY - 2014

Y1 - 2014

N2 - We searched MEDLINE, EMBASE and the Cochrane Controlled Trials Register to determine whether oxygen relieves dyspnoea in mildly or non-hypoxemic COPD and included 18 randomised controlled trials (431 participants) in the meta-analysis using Cochrane methodology. Oxygen therapy reduced dyspnoea when compared with medical air; standardised mean difference -0.37 (95% CI -0.50 to -0.24; I2=14%). In a priori subgroup and sensitivity analyses, dyspnoea was reduced by continuous oxygen during exertion but not short-burst oxygen therapy. Continuous exertional oxygen can relieve dyspnoea in mildly or non-hypoxemic COPD, but evidence from larger clinical trials is needed.

AB - We searched MEDLINE, EMBASE and the Cochrane Controlled Trials Register to determine whether oxygen relieves dyspnoea in mildly or non-hypoxemic COPD and included 18 randomised controlled trials (431 participants) in the meta-analysis using Cochrane methodology. Oxygen therapy reduced dyspnoea when compared with medical air; standardised mean difference -0.37 (95% CI -0.50 to -0.24; I2=14%). In a priori subgroup and sensitivity analyses, dyspnoea was reduced by continuous oxygen during exertion but not short-burst oxygen therapy. Continuous exertional oxygen can relieve dyspnoea in mildly or non-hypoxemic COPD, but evidence from larger clinical trials is needed.

U2 - 10.1136/thoraxjnl-2014-205720

DO - 10.1136/thoraxjnl-2014-205720

M3 - Review article

VL - 70

SP - 492

EP - 494

JO - Thorax

JF - Thorax

SN - 0040-6376

IS - 5

ER -